JPS591465A - 4―シアノ―2―アゼチジノン誘導体の製造法 - Google Patents

4―シアノ―2―アゼチジノン誘導体の製造法

Info

Publication number
JPS591465A
JPS591465A JP58073470A JP7347083A JPS591465A JP S591465 A JPS591465 A JP S591465A JP 58073470 A JP58073470 A JP 58073470A JP 7347083 A JP7347083 A JP 7347083A JP S591465 A JPS591465 A JP S591465A
Authority
JP
Japan
Prior art keywords
group
compound
azetidinone
cyano
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58073470A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0425264B2 (no
Inventor
Michihiko Ochiai
落合 道彦
Taisuke Matsuo
松尾 泰介
Shoji Kishimoto
岸本 彰二
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of JPS591465A publication Critical patent/JPS591465A/ja
Publication of JPH0425264B2 publication Critical patent/JPH0425264B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58073470A 1982-04-27 1983-04-25 4―シアノ―2―アゼチジノン誘導体の製造法 Granted JPS591465A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MC82/00141 1982-04-27
PCT/JP1982/000141 WO1983003827A1 (en) 1982-04-27 1982-04-27 4-cyano-2-azetidinone derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
JPS591465A true JPS591465A (ja) 1984-01-06
JPH0425264B2 JPH0425264B2 (no) 1992-04-30

Family

ID=13762237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58073470A Granted JPS591465A (ja) 1982-04-27 1983-04-25 4―シアノ―2―アゼチジノン誘導体の製造法

Country Status (3)

Country Link
JP (1) JPS591465A (no)
NZ (1) NZ202907A (no)
WO (1) WO1983003827A1 (no)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5846066A (ja) * 1981-08-27 1983-03-17 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト β−ラクタム類

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5846066A (ja) * 1981-08-27 1983-03-17 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト β−ラクタム類

Also Published As

Publication number Publication date
WO1983003827A1 (en) 1983-11-10
NZ202907A (en) 1986-01-24
JPH0425264B2 (no) 1992-04-30

Similar Documents

Publication Publication Date Title
GB2128986A (en) Derivatives of 6 b-hydroxalkylpenicillanic acids as b-lactamase inhibitors
JPS6011917B2 (ja) 新規なセファロスポリン化合物
IE55839B1 (en) Azetidine compounds
JPS61122285A (ja) 3位置換カルバセフエム化合物
JPS58213788A (ja) β‐ラクタマーゼ阻害剤を有するアンピシリンおよびアモキシシリン誘導体
US4560508A (en) 4-Cyano-2-azetidinones and production thereof
JPS58113174A (ja) 新規なアゼチジン誘導体またはその塩類を含有する抗菌剤
JPS591465A (ja) 4―シアノ―2―アゼチジノン誘導体の製造法
JPH0321544B2 (no)
KR890002107B1 (ko) 세팔로스포린 유도체의 제조방법
US4416817A (en) 3-Methoxy-2-oxoazetidine derivatives and their production
JPS641468B2 (no)
WO1993018030A1 (en) Benzimidazole derivatives as angiotensin ii antagonists
US5821362A (en) Method of desilylating silylether compounds
US4533495A (en) Method of producing 2-azetidinone-1-sulfonic acid compounds
PL145972B1 (en) Method of obtaining cephalosporin
JPH0239519B2 (no)
EP0298101A1 (en) Thiol-reactive cross-linking reagents
JPS641467B2 (no)
JPH0424347B2 (no)
JPS63107977A (ja) イソオキサゾロン誘導体
WO1982001872A1 (en) Azetidine derivatives and process for their preparation
JPH06122659A (ja) シクロプロペノン誘導体
JPS6348286A (ja) イミノ化合物およびその製法
JPS5953272B2 (ja) オキサセフアロスポリン類